Replies to post #37 on Biotime

[Paulness]

I am very confused about this PR , if they acquired assets for 250 thousand why did they issue 261 thousand shares as part of deal wouldn't that make the deal worth over 2 million at the time of the PR. Hmmm. I sold at $8.80 but thinking that this may relax a lot more because of this type of PRs. I am looking to get in at a lower PPS now obviously buying low selling high is the way to make money .

ALAMEDA, Calif. (AP) -- BioTime Inc. said Friday it has acquired substantially all the assets from biotech company Cell Targeting Inc. for $250,000, a move aimed at bolstering its slate of embryonic stem-cell therapy products.

BioTime issued 261,959 common shares as part of the deal and its stock fell 62 cents, or 7.6 percent, to $7.51 on Friday